Processa Pharmaceuticals, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
2.79M
on 2026-06-30, from 114K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-25 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
S-3 of 2024-05-21. Not read yet. S-3 ↗
4 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-14 is not read yet.
Cash
0.1 quarters
$196K on 2026-06-30 ÷ $3.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-08-04 | Private placement | 5,467,181 | $0.23 | $1.3M | 8-K ↗ |
| 2025-07-25 | Public offering | not read | not read | not read | 424B5 ↗ |
| 2025-06-17 | Public offering incl. 13.69M pre-funded, with warrants at $0.25 | 28,000,000 | $0.25 | $7.0M | 424B4 ↗ |
Also on file: a 1-for-25 reverse split, 2025-12-12 8-K ↗